CROSSJECT (ALCJ.PA) Stock Price & Overview
EPA:ALCJ • FR0011716265
Current stock price
The current stock price of ALCJ.PA is 1.984 EUR. Today ALCJ.PA is up by 1.22%. In the past month the price increased by 0.2%. In the past year, price increased by 130.7%.
ALCJ.PA Key Statistics
- Market Cap
- 104.835M
- P/E
- N/A
- Fwd P/E
- 7.41
- EPS (TTM)
- -0.23
- Dividend Yield
- N/A
ALCJ.PA Stock Performance
ALCJ.PA Stock Chart
ALCJ.PA Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to ALCJ.PA. When comparing the yearly performance of all stocks, ALCJ.PA is one of the better performing stocks in the market, outperforming 95.39% of all stocks.
ALCJ.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ALCJ.PA. ALCJ.PA has a bad profitability rating. Also its financial health evaluation is rather negative.
ALCJ.PA Earnings
ALCJ.PA Forecast & Estimates
10 analysts have analysed ALCJ.PA and the average price target is 3.94 EUR. This implies a price increase of 98.79% is expected in the next year compared to the current price of 1.984.
For the next year, analysts expect an EPS growth of 153.27% and a revenue growth 252.41% for ALCJ.PA
ALCJ.PA Groups
Sector & Classification
ALCJ.PA Financial Highlights
Over the last trailing twelve months ALCJ.PA reported a non-GAAP Earnings per Share(EPS) of -0.23. The EPS increased by 13.8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -35.89% | ||
| ROE | -308.38% | ||
| Debt/Equity | 2.52 |
ALCJ.PA Ownership
ALCJ.PA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| EL | ESSILORLUXOTTICA | 26.04 | 92.311B | ||
| ESL | ESSILORLUXOTTICA | 26.04 | 92.287B | ||
| 1EL | ESSILORLUXOTTICA | 25.99 | 92.102B | ||
| CVX | CARVOLIX SA | N/A | 186.606M | ||
| GBT | GUERBET | N/A | 117.805M | ||
| PTP | PENTIXAPHARM HOLDING AG | N/A | 48.484M |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About ALCJ.PA
Company Profile
Crossject SA manufactures and markets needle free injection system. The company is headquartered in Dijon, Bourgogne-Franche-Comte and currently employs 103 full-time employees. The company went IPO on 2014-02-20. The firm specializes in needle-free, pre-filled, single-use injection systems for intradermal, subcutaneous, and intramuscular applications for pharmaceutical companies. Is also has a pipeline and three drugs in the preclinical or clinical phase of research. The firm's products, which are based on well-known injectable drugs (chemicals and biologics), are designed to enhance patients' safety, compliance, and comfort. The firm has industrial partnerships with Hirtenberger and Recipharm. The company provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
Company Info
IPO: 2014-02-20
CROSSJECT
Parc Mazen-Sully, 6 Rue Pauline Kergomard
Dijon BOURGOGNE-FRANCHE-COMTE FR
Employees: 103
Phone: 33380549850
CROSSJECT / ALCJ.PA FAQ
What does ALCJ do?
Crossject SA manufactures and markets needle free injection system. The company is headquartered in Dijon, Bourgogne-Franche-Comte and currently employs 103 full-time employees. The company went IPO on 2014-02-20. The firm specializes in needle-free, pre-filled, single-use injection systems for intradermal, subcutaneous, and intramuscular applications for pharmaceutical companies. Is also has a pipeline and three drugs in the preclinical or clinical phase of research. The firm's products, which are based on well-known injectable drugs (chemicals and biologics), are designed to enhance patients' safety, compliance, and comfort. The firm has industrial partnerships with Hirtenberger and Recipharm. The company provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
Can you provide the latest stock price for CROSSJECT?
The current stock price of ALCJ.PA is 1.984 EUR. The price increased by 1.22% in the last trading session.
Does CROSSJECT pay dividends?
ALCJ.PA does not pay a dividend.
How is the ChartMill rating for CROSSJECT?
ALCJ.PA has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What sector and industry does CROSSJECT belong to?
CROSSJECT (ALCJ.PA) operates in the Health Care sector and the Health Care Equipment & Supplies industry.